Terence Ketter

Psychiatrist

Professor of Psychiatry and Behavioral Sciences

Outpatient Psychiatry Clinic

  • 401 Quarry Road
  • Stanford, CA 94304
  • Phone: 650-498-9111
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Internship: Univ of California San Francisco (1985) CA

Residency: UCSF Medical Center (1988) CA

Fellowship: National Institute of Health (1995) MD

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1989)

Medical Education: University of Toronto (1984) Canada

BSc, University of Toronto, Mathematics (1973)

MSc, Sydney University, Mathematics (1976)

Honors & Awards

Distinguished Fellow, American Psychiatric Association (2006)

Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (2003-2005)

Outstanding Faculty Physician Award, Vaden Health Center, Stanford University (2002)

Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (1999-2001)

Independent Investigator Award, Stanley Foundation Research Award Program (1996-2000)

Mead Johnson Travel Award Fellow, American College of Neuropsychopharmacology (1994)

Creative Resident Award, University of California, San Francisco (1988)

Walter F. Watkins Scholarship, University of Toronto School of Medicine (1982)

Governor General's Silver Medal, Erindale College, University of Toronto (1973)

Administrative Appointments

Chief, Bipolar Disorders Clinic (1995 - Present)

Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Bobo, W. V., Reilly-Harrington, N. A., Ketter, T. A., Brody, B. D., Kinrys, G., & Kamali, M. (2014). Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. Journal of affective disorders, 161, 30-35.

Medication adherence in a comparative effectiveness trial for bipolar disorder
Sylvia, L. G., Reilly-Harrington, N. A., Leon, A. C., Kansky, C. I., Calabrese, J. R., & Nierenberg, A. A. (2014). Medication adherence in a comparative effectiveness trial for bipolar disorder. ACTA PSYCHIATRICA SCANDINAVICA, 129(5), 359-365.

Update on best practices for managing bipolar depression.
Sachs, G. S., & Ketter, T. A. (2014). Update on best practices for managing bipolar depression. journal of clinical psychiatry, 75(5), e413-6.

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)
Beech, R. D., Leffert, J. J., Lin, A., Sylvia, L. G., Umlauf, S., & Nierenberg, A. (2014). Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). PHARMACOGENOMICS JOURNAL, 14(2), 182-191.

Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women.
Kenna, H. A., Reynolds-May, M., Stepanenko, A., Ketter, T. A., Hallmayer, J., & Rasgon, N. L. (2014). Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. Journal of affective disorders, 156, 214-218.

Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Shesler, L. W., & Calabrese, J. R. (2014). Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clinical trials , 11(1), 114-127.

Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls
Reynolds-May, M. F., Kenna, H. A., Marsh, W., Stemmle, P. G., Wang, P., & Rasgon, N. L. (2014). Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls. BIPOLAR DISORDERS, 16(1), 37-47.

Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome, L., Ketter, T. A., Cucchiaro, J., & Loebel, A. (2014). Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of affective disorders, 155, 20-27.

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials
Friedman, E. S., Calabrese, J. R., Ketter, T. A., Leon, A. C., Thase, M. E., & Reilly-Harrington, N. A. (2014). Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials. JOURNAL OF AFFECTIVE DISORDERS, 152, 97-104.

General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial
Kemp, D. E., Sylvia, L. G., Calabrese, J. R., Nierenberg, A. A., Thase, M. E., & Iosifescu, D. V. (2014). General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. ACTA PSYCHIATRICA SCANDINAVICA, 129(1), 24-34.

Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.
Sylvia, L. G., Friedman, E. S., Kocsis, J. H., Bernstein, E. E., Brody, B. D., & Nierenberg, A. A. (2013). Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. Journal of affective disorders, 151(2), 722-727.

Number needed to treat can be helpful: a response to Alphs et al.
Citrome, L., & Ketter, T. A. (2013). Number needed to treat can be helpful: a response to Alphs et al. European neuropsychopharmacology , 23(11), 1656-1657.

Use of Treatment Services in a Comparative Effectiveness Study of Bipolar Disorder
Sylvia, L. G., Iosifescu, D., Friedman, E. S., Bernstein, E. E., Bowden, C. L., & Nierenberg, A. A. (2013). Use of Treatment Services in a Comparative Effectiveness Study of Bipolar Disorder. PSYCHIATRIC SERVICES, 64(11), 1119-1126.

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., & Vieta, E. (2013). The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. AMERICAN JOURNAL OF PSYCHIATRY, 170(11), 1249-1262.

Number needed to harm can be clinically useful: a response to Safer and Zito.
Citrome, L., & Ketter, T. A. (2013). Number needed to harm can be clinically useful: a response to Safer and Zito. journal of nervous and mental disease, 201(11), 1001-1002.

The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research
Reilly-Harrington, N. A., Sylvia, L. G., Leon, A. C., Shesler, L. W., Ketter, T. A., & Nierenberg, A. A. (2013). The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. JOURNAL OF PSYCHIATRIC RESEARCH, 47(11), 1686-1693.

First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.
Suppes, T., Ketter, T. A., Gwizdowski, I. S., Dennehy, E. B., Hill, S. J., & Cosgrove, V. E. (2013). First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo. Journal of affective disorders, 150(1), 37-43.

Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder
Frye, M. A., Ketter, T. A., & Yang, R. (2013). Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder. BIPOLAR DISORDERS, 15, 126-127.

Bipolar disorder and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: evidence-based approach to diagnosis and treatment.
Miller, S., Chang, K. D., & Ketter, T. A. (2013). Bipolar disorder and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: evidence-based approach to diagnosis and treatment. journal of clinical psychiatry, 74(6), 628-629.

Lurasidone treatment for bipolar I depression: effects on quality of life and patient's functioning
Ketter, T. A., Cucchiaro, J., Silva, R., Pikalov, A., Sarma, K., & Loebel, A. (2013). Lurasidone treatment for bipolar I depression: effects on quality of life and patient's functioning. BIPOLAR DISORDERS, 15, 91-91.

Use of a novel adjunctive clinical trial design to examine efficacy, safety, and improved generalizability of armodafinil for the treatment of bipolar I depression
Calabrese, J. R., Frye, M. A., Yang, R., & Ketter, T. A. (2013). Use of a novel adjunctive clinical trial design to examine efficacy, safety, and improved generalizability of armodafinil for the treatment of bipolar I depression. BIPOLAR DISORDERS, 15, 59-59.

A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder
Ketter, T. A., Calabrese, J. R., Yang, R., & Frye, M. A. (2013). A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder. BIPOLAR DISORDERS, 15, 88-88.

Novel Compounds for Acute Management of Bipolar Depression
Frye, M. A., Calabrese, J. R., Yang, R., & Ketter, T. (2013). Novel Compounds for Acute Management of Bipolar Depression. BIPOLAR DISORDERS, 15, 13-13.

When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome, L., & Ketter, T. A. (2013). When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. International journal of clinical practice, 67(5), 407-411.

USE OF A NOVEL ADJUNCTIVE CLINICAL TRIAL DESIGN TO EXAMINE EFFICACY, SAFETY OF ARMODAFINIL FOR THE TREATMENT OF BIPOLAR I DEPRESSION
Calabrese, J. R., Ketter, T. A., Yang, R., & Frye, M. A. (2013). USE OF A NOVEL ADJUNCTIVE CLINICAL TRIAL DESIGN TO EXAMINE EFFICACY, SAFETY OF ARMODAFINIL FOR THE TREATMENT OF BIPOLAR I DEPRESSION. VALUE IN HEALTH, 16(3), A51-A52.

A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF ADJUNCTIVE ARMODAFINIL FOR THE TREATMENT OF MAJOR DEPRESSION ASSOCIATED WITH BIPOLAR I DISORDER
Frye, M. A., Ketter, T. A., Yang, R., & Calabrese, J. R. (2013). A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF ADJUNCTIVE ARMODAFINIL FOR THE TREATMENT OF MAJOR DEPRESSION ASSOCIATED WITH BIPOLAR I DISORDER. VALUE IN HEALTH, 16(3), A55-A56.

Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course
Miller, S., Hallmayer, J., Wang, P. W., Hill, S. J., Johnson, S. L., & Ketter, T. A. (2013). Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. JOURNAL OF PSYCHIATRIC RESEARCH, 47(2), 252-258.

Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium
Nierenberg, A. A., Friedman, E. S., Bowden, C. L., Sylvia, L. G., Thase, M. E., & Calabrese, J. R. (2013). Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium. AMERICAN JOURNAL OF PSYCHIATRY, 170(1), 102-110.

Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient.
Ittasakul, P., Srivastava, S., Hiranyatheb, T., & Ketter, T. A. (2012). Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient. Asian journal of psychiatry, 5(4), 365-366.

Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder
Miller, S., Ittasakul, P., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2012). Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 32(6), 814-819.

Addressing challenges in bipolar diagnosis: what do good clinicians already do? An editorial comment to Phelps J, Ghaemi SN 'The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11'.
Ketter, T. A., & Citrome, L. (2012). Addressing challenges in bipolar diagnosis: what do good clinicians already do? An editorial comment to Phelps J, Ghaemi SN 'The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11'. Acta psychiatrica Scandinavica, 126(6), 393-394.

Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients
Ittasakul, P., Johnson, K., Srivastava, S., Childers, M., Brook, J., & Ketter, T. (2012). Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients. ASIA-PACIFIC PSYCHIATRY, 4, 117-118.

Progression of female reproductive stages associated with bipolar illness exacerbation
Marsh, W. K., Ketter, T. A., Crawford, S. L., Johnson, J. V., Kroll-Desrosiers, A. R., & Rothschild, A. J. (2012). Progression of female reproductive stages associated with bipolar illness exacerbation. BIPOLAR DISORDERS, 14(5), 515-526.

Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients
Srivastava, S., Wang, P. W., Hill, S. J., Childers, M. E., Keller, K. L., & Ketter, T. A. (2012). Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients. JOURNAL OF PSYCHIATRIC RESEARCH, 46(7), 920-926.

Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients
Ittasakul, P., Johnson, K. R., Srivastava, S., Childers, M. E., Brooks, J. O., & Ketter, T. A. (2012). Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients. JOURNAL OF AFFECTIVE DISORDERS, 137(1-3), 139-145.

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
Carlson, B. X., Ketter, T. A., Sun, W., Timko, K., McQuade, R. D., & Marcus, R. (2012). Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). BIPOLAR DISORDERS, 14(1), 41-53.

Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder
Sylvia, L. G., Reilly-Harrington, N. A., Leon, A. C., Kansky, C. I., Ketter, T. A., & Nierenberg, A. A. (2012). Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. CLINICAL TRIALS, 9(1), 94-101.

Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Bowden, C. L., Perlis, R. H., Thase, M. E., Ketter, T. A., Ostacher, M. M., & Sachs, G. S. (2012). Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). CNS NEUROSCIENCE & THERAPEUTICS, 18(3), 243-249.

Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects
Srivastava, S., & Ketter, T. A. (2011). Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects. CLINICAL THERAPEUTICS, 33(12), B40-B48.

Sleep matters: Sleep functioning and course of illness in bipolar disorder
Gruber, J., Miklowitz, D. J., Harvey, A. G., Frank, E., Kupfer, D., & Ketter, T. A. (2011). Sleep matters: Sleep functioning and course of illness in bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 134(1-3), 416-420.

Gender-specific lipid profiles in patients with bipolar disorder
Vemuri, M., Kenna, H. A., Wang, P. W., Ketter, T. A., & Rasgon, N. L. (2011). Gender-specific lipid profiles in patients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1036-1041.

Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
Wang, P. W., Hill, S. J., Childers, M. E., Chandler, R. A., Rasgon, N. L., & Ketter, T. A. (2011). Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1128-1132.

Strategies for the early recognition of bipolar disorder.
Ketter, T. A. (2011). Strategies for the early recognition of bipolar disorder. journal of clinical psychiatry, 72(7).

DSM-5 mixed features specifier may increase complexity without enhancing milder mixed symptom detection in bipolar disorder patients: a 36 case series
Ketter, T. A., Srivastava, S., Wang, P. W., Childers, M. E., Hill, S. J., & Keller, K. L. (2011). DSM-5 mixed features specifier may increase complexity without enhancing milder mixed symptom detection in bipolar disorder patients: a 36 case series. BIPOLAR DISORDERS, 13, 62-62.

Pilot study of the effectiveness of double-blind, placebo-controlled brief olanzapine therapy in heterogeneous symptomatic bipolar disorder patients
Srivastava, S., Wang, P. W., Childers, M. E., Hill, S. J., Keller, K. L., & Ketter, T. A. (2011). Pilot study of the effectiveness of double-blind, placebo-controlled brief olanzapine therapy in heterogeneous symptomatic bipolar disorder patients. BIPOLAR DISORDERS, 13, 93-94.

Effectiveness of Aripiprazole in Bipolar Disorder Patients Primarily Taking Complex Pharmacotherapy
Ittasakul, P., Srivastava, S., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2011). Effectiveness of Aripiprazole in Bipolar Disorder Patients Primarily Taking Complex Pharmacotherapy. BIOLOGICAL PSYCHIATRY, 69(9), 92S-92S.

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
Ketter, T. A., Citrome, L., Wang, P. W., Culver, J. L., & Srivastava, S. (2011). Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?. ACTA PSYCHIATRICA SCANDINAVICA, 123(3), 175-189.

Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder
Brooks, J. O., Goldberg, J. F., Ketter, T. A., Miklowitz, D. J., Calabrese, J. R., & Thase, M. E. (2011). Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 72(2), 240-247.

Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression
Ahn, Y. M., Nam, J. Y., Culver, J. L., Marsh, W. K., Bonner, J. C., & Ketter, T. A. (2011). Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression. ANNALS OF CLINICAL PSYCHIATRY, 23(1), 17-24.

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes
Houston, J. P., Ketter, T. A., Case, M., Bowden, C., Degenhardt, E. K., & Tohen, M. (2011). Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. JOURNAL OF PSYCHIATRIC RESEARCH, 45(2), 169-173.

Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder
Brooks, J. O., Bearden, C. E., Hoblyn, J. C., Woodard, S. A., & Ketter, T. A. (2010). Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder. BIPOLAR DISORDERS, 12(8), 866-874.

The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies
Srivastava, S., & Ketter, T. A. (2010). The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies. CURRENT PSYCHIATRY REPORTS, 12(6), 522-530.

In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005
Severus, W. E., Lipkovich, I. A., Licht, R. W., Young, A. H., Greil, W., & Tohen, M. (2010). In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005. EUROPEAN PSYCHIATRY, 25(8), 443-449.

What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials?
March, J., Kraemer, H. C., Trivedi, M., Csernansky, J., Davis, J., & Glick, I. D. (2010). What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials?. NEUROPSYCHOPHARMACOLOGY, 35(13), 2491-2501.

Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J. M., Yang, R., & Frye, M. A. (2010). Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study. JOURNAL OF CLINICAL PSYCHIATRY, 71(10), 1363-1370.

Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Holland, A. A., Nam, J. Y., & Bonner, J. C. (2010). Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. JOURNAL OF PSYCHIATRIC RESEARCH, 44(14), 921-929.

Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder.
Ketter, T. A. (2010). Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder. journal of clinical psychiatry, 71(10).

Higher prevalence of bipolar I disorder among Asian and Latino compared to Caucasian patients receiving treatment
Hwang, S. Hj., Childers, M. E., Wang, P. W., Nam, J. Y., Keller, K. L., & Ketter, T. A. (2010). Higher prevalence of bipolar I disorder among Asian and Latino compared to Caucasian patients receiving treatment. ASIA-PACIFIC PSYCHIATRY, 2(3), 156-165.

Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: A controlled study
Srivastava, S., Childers, M. E., Baek, J. H., Strong, C. M., Hill, S. J., & Ketter, T. A. (2010). Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: A controlled study. JOURNAL OF AFFECTIVE DISORDERS, 125(1-3), 27-34.

Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus
Rasgon, N. L., Kenna, H. A., Reynolds-May, M. F., Stemmle, P. G., Vemuri, M., & Ketter, T. A. (2010). Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. BIPOLAR DISORDERS, 12(5), 504-513.

Divalproex extended-release in acute bipolar II depression
Wang, P. W., Nowakowska, C., Chandler, R. A., Hill, S. J., Nam, J. Y., & Ketter, T. A. (2010). Divalproex extended-release in acute bipolar II depression. JOURNAL OF AFFECTIVE DISORDERS, 124(1-2), 170-173.

Diagnostic features, prevalence, and impact of bipolar disorder.
Ketter, T. A. (2010). Diagnostic features, prevalence, and impact of bipolar disorder. journal of clinical psychiatry, 71(6).

Metabolic evidence of corticolimbic dysregulation in bipolar mania
Brooks, J. O., Hoblyn, J. C., & Ketter, T. A. (2010). Metabolic evidence of corticolimbic dysregulation in bipolar mania. PSYCHIATRY RESEARCH-NEUROIMAGING, 181(2), 136-140.

Strategies for monitoring outcomes in patients with bipolar disorder.
Ketter, T. A. (2010). Strategies for monitoring outcomes in patients with bipolar disorder. Primary care companion to the Journal of clinical psychiatry, 12, 10-16.

Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder Efficacy and Tolerability
Singh, M. K., Ketter, T. A., & Chang, K. D. (2010). Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder Efficacy and Tolerability. DRUGS, 70(4), 433-442.

Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission
Ketter, T. A., Agid, O., Kapur, S., Loebel, A., Siu, C. O., & Romano, S. J. (2010). Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission. JOURNAL OF PSYCHIATRIC RESEARCH, 44(1), 8-14.

Linkage Disequilibrium Mapping of The Chromosome 6q21-22.31 Bipolar I Disorder Susceptibility Locus
Fan, J., Ionita-Laza, I., McQueen, M. B., Devlin, B., Purcell, S., & Smoller, J. W. (2010). Linkage Disequilibrium Mapping of The Chromosome 6q21-22.31 Bipolar I Disorder Susceptibility Locus. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 153B(1), 29-37.

Lithium treatment-moderate dose use study (LiTMUS) for bipolar disorder: rationale and design
Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Ketter, T. A., & Iosifescu, D. V. (2009). Lithium treatment-moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. CLINICAL TRIALS, 6(6), 637-648.

Resting Prefrontal Hypometabolism and Paralimbic Hypermetabolism Related to Verbal Recall Deficits in Euthymic Older Adults With Bipolar Disorder
Brooks, J. O., Rosen, A. C., Hoblyn, J. C., Woodard, S. A., Krasnykh, O., & Ketter, T. A. (2009). Resting Prefrontal Hypometabolism and Paralimbic Hypermetabolism Related to Verbal Recall Deficits in Euthymic Older Adults With Bipolar Disorder. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 17(12), 1022-1029.

Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study
Houston, J. P., Tohen, M., Degenhardt, E. K., Jamal, H. H., Liu, L. Ll., & Ketter, T. A. (2009). Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study. JOURNAL OF CLINICAL PSYCHIATRY, 70(11), 1540-1547.

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
Mansour, H. A., Talkowski, M. E., Wood, J., Chowdari, Kv., McClain, L., & Nimgaonkar, V. L. (2009). Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. BIPOLAR DISORDERS, 11(7), 701-710.

Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions.
Citrome, L., & Ketter, T. A. (2009). Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. Journal of evidence-based medicine, 2(4), 220-225.

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo
Goldberg, J. F., Calabrese, J. R., Saville, B. R., Frye, M. A., Ketter, T. A., & Goodwin, F. K. (2009). Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo. JOURNAL OF CLINICAL PSYCHIATRY, 70(9), 1273-1280.

Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
Frye, M. A., Yatham, L., Ketter, T. A., Goldberg, J., Suppes, T., & Adams, B. (2009). Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies. ACTA PSYCHIATRICA SCANDINAVICA, 120(1), 10-13.

Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression
Brooks, J. O., Bonner, J. C., Rosen, A. C., Wang, P. W., Hoblyn, J. C., & Ketter, T. A. (2009). Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression. PSYCHIATRY RESEARCH-NEUROIMAGING, 172(3), 200-204.

Adjunctive armodafinil for major depression associated with bipolar I disorder: a randomized, double-blind, placebo-controlled study
Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J., Yang, R., & Frye, M. A. (2009). Adjunctive armodafinil for major depression associated with bipolar I disorder: a randomized, double-blind, placebo-controlled study. BIPOLAR DISORDERS, 11, 26-26.

The long term effectiveness of quetiapine plus lamotrigine therapy in bipolar patients
Ketter, T. A., Johnson, K., Childers, M., Srivastava, S., Brooks, J. O., & Hoblyn, J. C. (2009). The long term effectiveness of quetiapine plus lamotrigine therapy in bipolar patients. BIPOLAR DISORDERS, 11, 53-53.

Do positive emotions predict symptomatic change in bipolar disorder?
Gruber, J., Culver, J. L., Johnson, S. L., Nam, J. Y., Keller, K. L., & Ketter, T. A. (2009). Do positive emotions predict symptomatic change in bipolar disorder?. BIPOLAR DISORDERS, 11(3), 330-336.

Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison
Marsh, W. K., Ketter, T. A., & Rasgon, N. L. (2009). Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison. JOURNAL OF PSYCHIATRIC RESEARCH, 43(8), 798-802.

A Double-Blind, Placebo-Controlled Trial of Olanzapine Augmentation in Bipolar I Disorder, Mixed Episode
Houston, J. P., Tohen, M., Degenhardt, E., Jamal, H. H., Liu, L., & Ketter, T. A. (2009). A Double-Blind, Placebo-Controlled Trial of Olanzapine Augmentation in Bipolar I Disorder, Mixed Episode. BIOLOGICAL PSYCHIATRY, 65(8), 131S-131S.

Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Gruber, J., Harvey, A. G., Wang, P. W., Brooks, J. O., Thase, M. E., & Ketter, T. A. (2009). Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). JOURNAL OF AFFECTIVE DISORDERS, 114(1-3), 41-49.

Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions
Citrome, L., & Ketter, T. A. (2009). Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(3), 353-359.

Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder
Brooks, J. O., Hoblyn, J. C., Woodard, S. A., Rosen, A. C., & Ketter, T. A. (2009). Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(5), 497-502.

Treating bipolar disorder: monotherapy versus combination therapy.
Ketter, T. A. (2009). Treating bipolar disorder: monotherapy versus combination therapy. journal of clinical psychiatry, 70(2).

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD
Goldberg, J. F., Brooks, J. O., Kurita, K., Hoblyn, J. C., Ghaemi, N., & Thase, M. E. (2009). Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD. JOURNAL OF CLINICAL PSYCHIATRY, 70(2), 155-162.

Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.
Brooks, J. O., Wang, P. W., Bonner, J. C., Rosen, A. C., Hoblyn, J. C., & Ketter, T. A. (2009). Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Journal of psychiatric research, 43(3), 181-188.

Insulin resistance and hyperlipidemia in women with bipolar disorder.
Stemmle, P. G., Kenna, H. A., Wang, P. W., Hill, S. J., Ketter, T. A., & Rasgon, N. L. (2009). Insulin resistance and hyperlipidemia in women with bipolar disorder. Journal of psychiatric research, 43(3), 341-343.

Combination therapy versus monotherapy in bipolar disorder.
Ketter, T. A. (2008). Combination therapy versus monotherapy in bipolar disorder. journal of clinical psychiatry, 69(12).

Effectiveness of lamotrigine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Champion, L. M., Nam, J. Y., & Bonner, J. C. (2008). Effectiveness of lamotrigine in bipolar disorder in a clinical setting. JOURNAL OF PSYCHIATRIC RESEARCH, 43(1), 13-23.

Interregional cerebral metabolic associativity during a continuous performance task (Part II) : Differential alterations in bipolar and unipolar disorders
Benson, B. E., Willis, M. W., Ketter, T. A., Speer, A., Kimbrell, T. A., & Post, R. M. (2008). Interregional cerebral metabolic associativity during a continuous performance task (Part II) : Differential alterations in bipolar and unipolar disorders. PSYCHIATRY RESEARCH-NEUROIMAGING, 164(1), 30-47.

Interregional cerebral metabolic associativity during a continuous performance task (Part I): Healthy adults
Willis, M. W., Benson, B. E., Ketter, T. A., Kimbrell, T. A., George, M. S., & Post, R. M. (2008). Interregional cerebral metabolic associativity during a continuous performance task (Part I): Healthy adults. PSYCHIATRY RESEARCH-NEUROIMAGING, 164(1), 16-29.

A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities
Chandler, R. A., Wang, P. W., Ketter, T. A., & Goodwin, G. M. (2008). A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities. ACTA PSYCHIATRICA SCANDINAVICA, 118(1), 81-85.

Incorporating trial data into bipolar disorder management.
Ketter, T. A. (2008). Incorporating trial data into bipolar disorder management. journal of clinical psychiatry, 69(7).

Caregiver burden and health in bipolar disorder - A cluster analytic approach
Perlick, D. A., Rosenheck, R. A., Miklowitz, D. J., Kaczynski, R., Link, B., & Sachs, G. (2008). Caregiver burden and health in bipolar disorder - A cluster analytic approach. JOURNAL OF NERVOUS AND MENTAL DISEASE, 196(6), 484-491.

Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study
Wang, P. W., Yang, Y.- shou, Chandler, R. A., Nowakowska, C., Alarcon, A. M., & Ketter, T. A. (2008). Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study. JOURNAL OF PSYCHIATRIC RESEARCH, 42(6), 451-457.

Insulin resistance and hyperlipidemia in women with bipolar disorder
Rasgon, N. L., Stemmle, P. G., Kenna, H. A., Wong, P. W., Hill, S. J., & Ketter, T. A. (2008). Insulin resistance and hyperlipidemia in women with bipolar disorder. EUROPEAN PSYCHIATRY, 23, S235-S235.

Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report
Marsh, W. K., Templeton, A., Ketter, T. A., & Rasgon, N. L. (2008). Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report. JOURNAL OF PSYCHIATRIC RESEARCH, 42(3), 247-251.

Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
El-Mallakh, R. S., Ketter, T. A., Weisler, R. H., Hirschfeld, R., Cutler, A. J., & Kalali, A. H. (2008). Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania. PSYCHOPHARMACOLOGY BULLETIN, 41(1), 52-58.

Monotherapy Versus Combined Treatment With Second-Generation Antipsychotics in Bipolar Disorder
Ketter, T. A. (2008). Monotherapy Versus Combined Treatment With Second-Generation Antipsychotics in Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 69, 9-15.

Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder
Goldberg, J. F., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Dann, R. S., & Post, R. M. (2008). Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. BIOLOGICAL PSYCHIATRY, 63(1), 125-130.

Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder
Brooks, J. O., Wang, P. W., Bonner, J. C., Rosen, A. C., Hoblyn, J. C., & Ketter, T. A. (2008). Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(3), 181-188.

Insulin resistance and hyperlipidemia in women with bipolar disorder
Stemmle, P. G., Kenna, H. A., Wang, P. W., Hill, S. J., Ketter, T. A., & Rasgon, N. L. (2008). Insulin resistance and hyperlipidemia in women with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(3), 341-343.

Enhanced creativity in bipolar disorder patients: A controlled study
Santosa, C. A., Strong, C. M., Nowakowska, C., Wang, P. W., Rennicke, C. M., & Ketter, T. A. (2007). Enhanced creativity in bipolar disorder patients: A controlled study. JOURNAL OF AFFECTIVE DISORDERS, 100(1-3), 31-39.

Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals
Strong, C. M., Nowakowska, C., Santosa, C. M., Wang, P. W., Kraemer, H. C., & Ketter, T. A. (2007). Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals. JOURNAL OF AFFECTIVE DISORDERS, 100(1-3), 41-48.

Effectiveness of adjunctive antidepressant treatment for bipolar depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., & Thase, M. E. (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. NEW ENGLAND JOURNAL OF MEDICINE, 356(17), 1711-1722.

Relations between delayed memory and cerebral metabolism in older euthymic adults with bipolar disorder
Brooks, J. O., Hoblyn, J. C., Woodard, S., Rosen, A. C., Krasnykh, O., & Schatzberg, A. F. (2007). Relations between delayed memory and cerebral metabolism in older euthymic adults with bipolar disorder. BIOLOGICAL PSYCHIATRY, 61(8), 114S-114S.

Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study
Cookson, J., Keck, P. E., Ketterc, T. A., & Macfadden, W. (2007). Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 22(2), 93-100.

Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin
Sommer, B. R., Fenn, H. H., & Ketter, T. A. (2007). Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. EXPERT OPINION ON DRUG SAFETY, 6(2), 133-145.

Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness - Principles and practice
Post, R. M., Ketter, T. A., Uhde, T., & Ballenger, J. C. (2007). Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness - Principles and practice. CNS DRUGS, 21(1), 47-71.

Introduction - Advancing understanding of the effectiveness of quetiapine in acute mania
Ketter, T. A. (2007). Introduction - Advancing understanding of the effectiveness of quetiapine in acute mania. JOURNAL OF AFFECTIVE DISORDERS, 100, S1-S3.

Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania
Ketter, T. A., Jones, M., & Paulsson, B. (2007). Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. JOURNAL OF AFFECTIVE DISORDERS, 100, S45-S53.

Bipolar disorder: Improving diagnosis and optimizing integrated care
Culver, J. L., Arnow, B. A., & Ketter, T. A. (2007). Bipolar disorder: Improving diagnosis and optimizing integrated care. JOURNAL OF CLINICAL PSYCHOLOGY, 63(1), 73-92.

Effectiveness of quetiapine in a clinical setting
Ketter, T. A., Holland, A. A., Nam, J. Y., Culver, J. L., Wang, P. W., & Bonner, J. C. (2006). Effectiveness of quetiapine in a clinical setting. NEUROPSYCHOPHARMACOLOGY, 31, S234-S234.

Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice
Ketter, T. A., & Haupt, D. W. (2006). Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. CURRENT MEDICAL RESEARCH AND OPINION, 22(12), 2345-2353.

Overweight and obesity in bipolar disorders
Wang, P. W., Sachs, G. S., Zarate, C. A., Marangell, L. B., Calabrese, J. R., & Ketter, T. A. (2006). Overweight and obesity in bipolar disorders. JOURNAL OF PSYCHIATRIC RESEARCH, 40(8), 762-764.

Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials
Frye, M. A., Yatham, L. N., Calabrese, J. R., Bowden, C. L., Ketter, T. A., & Thompson, T. R. (2006). Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials. JOURNAL OF CLINICAL PSYCHIATRY, 67(11), 1721-1728.

Omega-3 fatty acids in bipolar disorder: Clinical and research considerations
Marangell, L. B., Suppes, T., Ketter, T. A., Dennehy, E. B., Zboyan, H., & Sachs, G. (2006). Omega-3 fatty acids in bipolar disorder: Clinical and research considerations. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 75(4-5), 315-321.

The use of antiepileptic drugs in bipolar disorders. A review based on evidence from controlled trials
Weisler, R. H., Cutler, A. J., Ballenger, J. C., Post, R. M., & Ketter, T. A. (2006). The use of antiepileptic drugs in bipolar disorders. A review based on evidence from controlled trials. CNS SPECTRUMS, 11(10), 788-799.

Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature
Nasrallah, H. A., Ketter, T. A., & Kalali, A. H. (2006). Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. JOURNAL OF AFFECTIVE DISORDERS, 95(1-3), 69-78.

Adjunctive aripiprazole in treatment-resistant bipolar depression.
Ketter, T. A., Wang, P. W., Chandler, R. A., Culver, J. L., & Alarcon, A. M. (2006). Adjunctive aripiprazole in treatment-resistant bipolar depression. Annals of clinical psychiatry , 18(3), 169-172.

Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder
Bowden, C. L., Calabrese, J. R., Ketter, T. A., Sachs, G. S., White, R. L., & Thompson, T. R. (2006). Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. AMERICAN JOURNAL OF PSYCHIATRY, 163(7), 1199-1201.

Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies
Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T., Frye, M., & Thompson, T. R. (2006). Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies. BIOLOGICAL PSYCHIATRY, 59(11), 1061-1064.

Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls
Brooks, J. O., Wang, P. W., Strong, C., Sachs, N., Hoblyn, J. C., & Ketter, T. A. (2006). Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. BIPOLAR DISORDERS, 8(3), 248-254.

Safety and tolerability of mood-stabilising anticonvulsants in the elderly
Fenn, H. H., Sommer, B. R., Ketter, T. A., & Alldredge, B. (2006). Safety and tolerability of mood-stabilising anticonvulsants in the elderly. EXPERT OPINION ON DRUG SAFETY, 5(3), 401-416.

Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder
Sachs, G., Bowden, C., Calabrese, J. R., Ketter, T., Thompson, T., & Bentley, B. (2006). Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. BIPOLAR DISORDERS, 8(2), 175-181.

Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders
Wang, P. W., Sailasuta, N., Chandler, R. A., & Ketter, T. A. (2006). Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. ACTA NEUROPSYCHIATRICA, 18(2), 120-126.

The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial
Ketter, T. A., Greist, J. H., Graham, J. A., Roberts, J. N., Thompson, T. R., & Nanry, K. P. (2006). The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial. JOURNAL OF CLINICAL PSYCHIATRY, 67(3), 400-406.

Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H. W., & Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 217-224.

Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., & Sachs, G. S. (2006). Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 210-216.

Extended-release carbamazepine capsules as monotherapy in bipolar disorder - Pooled results from two randomised, double-blind, placebo-controlled trials
Weisler, R. H., Hirschfeld, R., Cutler, A. J., Gazda, T., Ketter, T. A., & Kalali, A. (2006). Extended-release carbamazepine capsules as monotherapy in bipolar disorder - Pooled results from two randomised, double-blind, placebo-controlled trials. CNS DRUGS, 20(3), 219-231.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes
Ketter, T. A., Houston, J. P., Adams, D. H., Risser, R. C., Meyers, A. L., & Tohen, M. (2006). Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 67(1), 95-101.

Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter, T. A., Nasrallah, H. A., & Fagiolini, A. (2006). Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacology bulletin, 39(1), 120-146.

Clinical use of carbamazepine for bipolar disorders
Wang, P. W., & Ketter, T. A. (2005). Clinical use of carbamazepine for bipolar disorders. EXPERT OPINION ON PHARMACOTHERAPY, 6(16), 2887-2902.

Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls
Dunn, R. T., Willis, M. W., Benson, B. E., Repella, J. D., Kimbrell, T. A., & Post, R. M. (2005). Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. PSYCHIATRY RESEARCH-NEUROIMAGING, 140(2), 181-198.

Creativity in familial bipolar disorder
Simeonova, D. I., Chang, K. D., Strong, C., & Ketter, T. A. (2005). Creativity in familial bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 39(6), 623-631.

Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder
Chang, K., Barnea-Goraly, N., Karchemskiy, A., Simeonova, D. I., Barnes, P., & Reiss, A. L. (2005). Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder. BIOLOGICAL PSYCHIATRY, 58(3), 197-203.

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., & Mullen, J. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. AMERICAN JOURNAL OF PSYCHIATRY, 162(7), 1351-1360.

The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder
Suppes, T., Dennehy, E. B., Hirschfeld, R. Ma., Altshuler, L. L., Bowden, C. L., & Swann, A. C. (2005). The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder. JOURNAL OF CLINICAL PSYCHIATRY, 66(7), 870-886.

Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data
Ketter, T. A., Akiskal, H. S., Keck, P. E., Fuller, M. A., Weisler, R. H., & Hirschfeld, R. Ma. (2005). Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data. CNS SPECTRUMS, 1-13.

A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
Graham, J. A., Ketter, T. A., Roberts, J., DeVeaugh-Geiss, A. M., & Thompson, T. R. (2005). A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients. BIPOLAR DISORDERS, 7, 62-62.

The impact of polarity of subyndromal symptoms in bipolar maintenance studies
Yatham, L. N., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Adams, B. E., & Thompson, T. R. (2005). The impact of polarity of subyndromal symptoms in bipolar maintenance studies. BIPOLAR DISORDERS, 7, 113-113.

Olanzapine and lithium prophylaxis of bipolar disorder and episode history
Houston, J. P., Ketter, T. A., Risser, R. C., Adams, D. H., Meyers, A., & Tohen, M. (2005). Olanzapine and lithium prophylaxis of bipolar disorder and episode history. BIPOLAR DISORDERS, 7, 66-66.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression
Keck, P. E., Corya, S. A., Altshuler, L. L., Ketter, T. A., McElroy, S. L., & Tohen, M. (2005). Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. JOURNAL OF CLINICAL PSYCHIATRY, 66(5), 611-616.

Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash
Ketter, T. A., Wang, P. W., Chandler, R. A., Alarcon, A. M., Becker, O. V., & Schumacher, M. R. (2005). Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. JOURNAL OF CLINICAL PSYCHIATRY, 66(5), 642-645.

Olanzapine and lithium prophylaxis of bipolar disorder and episode history
Ketter, T., Houston, J. P., Risser, R. C., Adams, D. H., Meyers, A., & Tohen, M. (2005). Olanzapine and lithium prophylaxis of bipolar disorder and episode history. BIOLOGICAL PSYCHIATRY, 57(8), 54S-54S.

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial
Weisler, R. H., Keck, P. E., Swann, A. C., Cutler, A. J., Ketter, T. A., & Kalali, A. H. (2005). Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial. JOURNAL OF CLINICAL PSYCHIATRY, 66(3), 323-330.

Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls
Nowakowska, C., Strong, C. M., Santosa, C. M., Wang, P. W., & Ketter, T. A. (2005). Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. JOURNAL OF AFFECTIVE DISORDERS, 85(1-2), 207-215.

Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression
Little, J. T., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Benson, B. E., & Post, R. M. (2005). Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. BIOLOGICAL PSYCHIATRY, 57(3), 220-228.

Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter
Mansour, H. A., Talkowski, M. E., Wood, J., Pless, L., Bamne, M., & Nimgaonkar, V. L. (2005). Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter. ANNALS OF MEDICINE, 37(8), 590-602.

Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Kogan, J. N., Otto, M. W., Bauer, M. S., Dennehy, E. B., Miklowitz, D. J., & Sachs, G. S. (2004). Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). BIPOLAR DISORDERS, 6(6), 460-469.

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania
Baker, R. W., Brown, E., Akiskal, H. S., Calabrese, J. R., Ketter, T. A., & Tohen, M. (2004). Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. BRITISH JOURNAL OF PSYCHIATRY, 185, 472-478.

Phenomenology of rapid-cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program
Schneck, C. D., Miklowitz, D. J., Calabrese, J. R., Allen, M. H., Thomas, M. R., & Sachs, G. S. (2004). Phenomenology of rapid-cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program. AMERICAN JOURNAL OF PSYCHIATRY, 161(10), 1902-1908.

Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report
Becker, O. V., Rasgon, N. L., Marsh, W. K., Glenn, T., & Ketter, T. A. (2004). Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report. BIPOLAR DISORDERS, 6(5), 435-439.

A potential cholinergic mechanism of procaine's limbic activation
Benson, B. E., Carson, R. E., Kiesewetter, D. O., Herscovitch, P., Eckelman, W. C., & Ketter, T. A. (2004). A potential cholinergic mechanism of procaine's limbic activation. NEUROPSYCHOPHARMACOLOGY, 29(7), 1239-1250.

Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression
Tohen, M., Vieta, E., Calabrese, J., Ketter, T., Mitchell, P., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S331-S331.

Sustained remission/euthymia with quetiapine monotherapy for bipolar mania
Ketter, T. A., Paulsson, B., & Jones, M. (2004). Sustained remission/euthymia with quetiapine monotherapy for bipolar mania. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S330-S330.

A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes
Ketter, T. A., Kalali, A. H., & Weisler, R. H. (2004). A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 65(5), 668-673.

Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression
Tohen, M., Vieta, E., Calabrese, J. R., Ketter, T. A., Mitchell, P. B., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. BIOLOGICAL PSYCHIATRY, 55, 231S-231S.

Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD
Marangell, L. B., Martinez, J. M., Ketter, T. A., Bowden, C. L., Goldberg, J. F., & Thase, M. E. (2004). Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. BIPOLAR DISORDERS, 6(2), 139-143.

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes
Weisler, R. H., Kalali, A. H., & Ketter, T. A. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 65(4), 478-484.

Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression
Tohen, M., Vieta, E., Calabrese, J. R., Ketter, T. A., Mitchell, P., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. EUROPEAN PSYCHIATRY, 19, 204S-204S.

Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Lembke, A., Miklowitz, D. J., Otto, M. W., Zhang, H., Wisniewski, S. R., & Ketter, T. A. (2004). Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of psychiatric practice, 10(2), 81-87.

Sustained remission/euthymia with quetiapine monotherapy for bipolar mania
Ketter, T. A., Paulsson, B., & Jones, M. (2004). Sustained remission/euthymia with quetiapine monotherapy for bipolar mania. ACTA PSYCHIATRICA SCANDINAVICA, 110, 31-31.

Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?
Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y. S. (2004). Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?. JOURNAL OF PSYCHIATRIC RESEARCH, 38(1), 47-61.

New medication treatment options for bipolar disorders
Ketter, T. A., Wang, P. W., Nowakowska, C., & Marsh, W. K. (2004). New medication treatment options for bipolar disorders. ACTA PSYCHIATRICA SCANDINAVICA, 110, 18-33.

New anticonvulsant medication uses in bipolar disorder
Wang, P. W., Ketter, T. A., Becker, O. V., & Nowakowska, C. (2003). New anticonvulsant medication uses in bipolar disorder. CNS SPECTRUMS, 8(12), 930-?.

Studies of offspring of parents with bipolar disorder
Chang, K., Steiner, H., & Ketter, T. (2003). Studies of offspring of parents with bipolar disorder. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 123C(1), 26-35.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., & Breier, A. (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. ARCHIVES OF GENERAL PSYCHIATRY, 60(11), 1079-1088.

Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders
Ketter, T. A., Manji, H. K., & Post, R. M. (2003). Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 23(5), 484-495.

Temperament characteristics of child and adolescent bipolar offspring
Chang, K. D., Blasey, C. M., Ketter, T. A., & Steiner, H. (2003). Temperament characteristics of child and adolescent bipolar offspring. JOURNAL OF AFFECTIVE DISORDERS, 77(1), 11-19.

Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms
Chang, K. D., Dienes, K., Blasey, C., Adleman, N., Ketter, T., & Steiner, H. (2003). Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. JOURNAL OF CLINICAL PSYCHIATRY, 64(8), 936-942.

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study
Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., & Baker, R. W. (2003). Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study. AMERICAN JOURNAL OF PSYCHIATRY, 160(7), 1263-1271.

Bipolar offspring: A window into bipolar disorder evolution
Chang, K., Steiner, H., Dienes, K., Adleman, N., & Ketter, T. (2003). Bipolar offspring: A window into bipolar disorder evolution. BIOLOGICAL PSYCHIATRY, 53(11), 945-951.

Decreased N-acetylaspartate in children with familial bipolar disorder
Chang, K., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., & Ketter, T. (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. BIOLOGICAL PSYCHIATRY, 53(11), 1059-1065.

The diverse roles of anticonvulsants in bipolar disorders.
Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y.- shou. (2003). The diverse roles of anticonvulsants in bipolar disorders. Annals of clinical psychiatry , 15(2), 95-108.

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Sachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., & Rosenbaum, J. F. (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). BIOLOGICAL PSYCHIATRY, 53(11), 1028-1042.

The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders
Ketter, T. A., & Wang, P. W. (2003). The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. JOURNAL OF CLINICAL PSYCHIATRY, 64, 15-20.

The emerging role of olanzapine in bipolar disorders
Ketter, T. A., Wang, P. W., Janenawasin, S., Becker, O. V., & Wang, A. (2002). The emerging role of olanzapine in bipolar disorders. PSYCHIATRIC ANNALS, 32(12), 753-762.

Psychiatric uses of antiepileptic treatments
Boylan, L. S., Devinsky, O., Barry, J. J., & Ketter, T. A. (2002). Psychiatric uses of antiepileptic treatments. EPILEPSY & BEHAVIOR, 3(5), S54-S59.

Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M., Das, B., & Ketter, T. A. (2002). Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. BIPOLAR DISORDERS, 4(5), 328-334.

Gabapentin augmentation therapy in bipolar depression
Wang, P. W., Santosa, C., Schumacher, M., Winsberg, M. E., Strong, C., & Ketter, T. A. (2002). Gabapentin augmentation therapy in bipolar depression. BIPOLAR DISORDERS, 4(5), 296-301.

Olanzapine versus divalproex in the treatment of acute mania
Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., & Tollefson, G. A. (2002). Olanzapine versus divalproex in the treatment of acute mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(6), 1011-1017.

Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Li, X. H., Ketter, T. A., & Frye, M. A. (2002). Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?. JOURNAL OF AFFECTIVE DISORDERS, 69(1-3), 1-14.

3 Tesla 1h-magnetic resonance spectroscopic measurements of prefrontal cortical gamma-aminobutyric acid (GABA) levels in bipolar disorder patients and healthy volunteers
Wang, P. W., Dieckmann, N., Sailasuta, N., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2002). 3 Tesla 1h-magnetic resonance spectroscopic measurements of prefrontal cortical gamma-aminobutyric acid (GABA) levels in bipolar disorder patients and healthy volunteers. BIOLOGICAL PSYCHIATRY, 51(8), 197S-197S.

Principal components of the beck depression inventory and regional cerebral metabolism in unipolar and bipolar depression
Dunn, R. T., Kimbrell, T. A., Ketter, T. A., Frye, M. A., Willis, M. W., & Post, R. M. (2002). Principal components of the beck depression inventory and regional cerebral metabolism in unipolar and bipolar depression. BIOLOGICAL PSYCHIATRY, 51(5), 387-399.

Age, sex and laterality effects on cerebral glucose metabolism in healthy adults
Willis, M. W., Ketter, T. A., Kimbrell, T. A., George, M. S., Herscovitch, P., & Post, R. M. (2002). Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. PSYCHIATRY RESEARCH-NEUROIMAGING, 114(1), 23-37.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression
Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., & Post, R. M. (2002). Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. BIOLOGICAL PSYCHIATRY, 51(3), 237-252.

Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature
Ketter, T. A., & Calabrese, J. R. (2002). Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature. JOURNAL OF CLINICAL PSYCHIATRY, 63(2), 146-151.

Impaired recognition of facial emotion in mania
Lembke, A., & Ketter, T. A. (2002). Impaired recognition of facial emotion in mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(2), 302-304.

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders
Obrocea, G. V., Dunn, R. M., Frye, M. A., Ketter, T. A., Luckenbaugh, D. A., & Post, R. M. (2002). Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. BIOLOGICAL PSYCHIATRY, 51(3), 253-260.

Predictors of treatment response in bipolar disorders: Evidence from clinical and brain imaging studies
Ketter, T. A., & Wang, P. W. (2002). Predictors of treatment response in bipolar disorders: Evidence from clinical and brain imaging studies. JOURNAL OF CLINICAL PSYCHIATRY, 63, 21-25.

Pharmacokinetics of mood stabilizers and new anticonvulsants.
Wang, P. W., & Ketter, T. A. (2002). Pharmacokinetics of mood stabilizers and new anticonvulsants. Psychopharmacology bulletin, 36(1), 44-66.

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression
Winsberg, M. E., DeGolia, S. G., Strong, C. M., & Ketter, T. A. (2001). Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. JOURNAL OF AFFECTIVE DISORDERS, 67(1-3), 207-212.

Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men
Osuch, E. A., Cora-Locatelli, G., Frye, M. A., Huggins, T., Kimbrell, T. A., & Post, R. M. (2001). Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. ACTA PSYCHIATRICA SCANDINAVICA, 104(5), 397-401.

3 Tesla 1H-magnetic resonance spectroscopic (MRS) detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers
Wang, P. W., Sachs, N., Sailasuta, N., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2001). 3 Tesla 1H-magnetic resonance spectroscopic (MRS) detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers. BIOLOGICAL PSYCHIATRY, 49(8), 27S-27S.

Family environment of children and adolescents with bipolar parents
Chang, K. D., Blasey, C., Ketter, T. A., & Steiner, H. (2001). Family environment of children and adolescents with bipolar parents. BIPOLAR DISORDERS, 3(2), 73-78.

Special issues in the treatment of paediatric bipolar disorder.
Chang, K. D., & Ketter, T. A. (2001). Special issues in the treatment of paediatric bipolar disorder. Expert opinion on pharmacotherapy, 2(4), 613-622.

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder
Ketter, T. A., Kimbrell, T. A., George, M. S., Dunn, R. T., Speer, A. M., & Post, R. M. (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. BIOLOGICAL PSYCHIATRY, 49(2), 97-109.

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., & Post, R. M. (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 20(6), 607-614.

Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients
Osuch, E. A., Ketter, T. A., Kimbrell, T. A., George, M. S., Benson, B. E., & Post, R. M. (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. BIOLOGICAL PSYCHIATRY, 48(10), 1020-1023.

Biology and recent brain imaging studies in affective psychoses.
Wang, P. W., & Ketter, T. A. (2000). Biology and recent brain imaging studies in affective psychoses. Current psychiatry reports, 2(4), 298-304.

Psychiatric phenomenology of child and adolescent bipolar offspring
Chang, K. Kd., Steiner, H., & Ketter, T. A. (2000). Psychiatric phenomenology of child and adolescent bipolar offspring. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 39(4), 453-460.

Mood stabilizer augmentation with olanzapine in acutely manic children
Chang, K. D., & Ketter, T. A. (2000). Mood stabilizer augmentation with olanzapine in acutely manic children. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 10(1), 45-49.

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder
Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. BIOLOGICAL PSYCHIATRY, 47(6), 475-481.

The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study
Frye, M. A., Ketter, T. A., Leverich, G. S., Huggins, T., Lantz, C., & Post, R. M. (2000). The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. JOURNAL OF CLINICAL PSYCHIATRY, 61(1), 9-15.

Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
Ketter, T. A., Kimbrell, T. A., George, M. S., Willis, M. W., Benson, B. E., & Post, R. M. (1999). Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. BIOLOGICAL PSYCHIATRY, 46(10), 1364-1374.

Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
Ketter, T. A., Post, R. M., & Theodore, W. H. (1999). Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. NEUROLOGY, 53(5), S53-S67.

Regional brain activity during transient self-induced anxiety and anger in healthy adults
Kimbrell, T. A., George, M. S., Parekh, P. I., Ketter, T. A., Podell, D. M., & Post, R. M. (1999). Regional brain activity during transient self-induced anxiety and anger in healthy adults. BIOLOGICAL PSYCHIATRY, 46(4), 454-465.

Metabolism and excretion of mood stabilizers and new anticonvulsants
Ketter, T. A., Frye, M. A., Cora-Locatelli, G., Kimbrell, T. A., & Post, R. M. (1999). Metabolism and excretion of mood stabilizers and new anticonvulsants. CELLULAR AND MOLECULAR NEUROBIOLOGY, 19(4), 511-532.

Differences in dorsolateral prefrontal cortex N-acetyl aspartate in bipolar disorder subtypes using 1H MRS
Winsberg, M. E., Sachs, N., Tate, D. L., Spielman, D. M., & Ketter, T. A. (1999). Differences in dorsolateral prefrontal cortex N-acetyl aspartate in bipolar disorder subtypes using 1H MRS. BIOLOGICAL PSYCHIATRY, 45(8), 125S-125S.

Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression
Little, J. T., Ketter, T. A., Mathe, A. A., Frye, M. A., Luckenbaugh, D., & Post, R. M. (1999). Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. BIOLOGICAL PSYCHIATRY, 45(3), 285-289.

Gabapentin does not alter single-dose lithium pharmacokinetics
Frye, M. A., Kimbrell, T. A., Dunn, R. T., Piscitelli, S., Grothe, D., & Ketter, T. A. (1998). Gabapentin does not alter single-dose lithium pharmacokinetics. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 18(6), 461-464.

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness
Pazzaglia, P. J., Post, R. M., Ketter, T. A., Callahan, A. M., Marangell, L. B., & Luckenbaugh, D. (1998). Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 18(5), 404-413.

A potential cholinergic mechanism of procaine's limbic activation
Benson, B. E., Carson, R. E., Sandoval, W., Linthicum, W. L., Kimbrell, T. A., & Ketter, T. A. (1998). A potential cholinergic mechanism of procaine's limbic activation. BIOLOGICAL PSYCHIATRY, 43, 27S-28S.

Brain imaging studies of treatments in mood disorders
Ketter, T. A., Kennedy, S. H., Kimbrell, T. A., Wu, J. C., Sackeim, H. A., & George, M. S. (1998). Brain imaging studies of treatments in mood disorders. BIOLOGICAL PSYCHIATRY, 43, 61S-61S.

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder
Winsberg, M. E., Sachs, N., Tate, D. L., Dunai, M., Strong, C. M., & Ketter, T. A. (1998). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. BIOLOGICAL PSYCHIATRY, 43, 23S-23S.

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
Frye, M. A., Ketter, T. A., Altshuler, L. L., Denicoff, K., Dunn, R. T., & Post, R. M. (1998). Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. JOURNAL OF AFFECTIVE DISORDERS, 48(2-3), 91-104.

Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients
Parekh, P. I., Ketter, T. A., Altshuler, L., Frye, M. A., Callahan, A., & Post, R. M. (1998). Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients. BIOLOGICAL PSYCHIATRY, 43(5), 392-394.

Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states
Ketter, T. A., Winsberg, M. E., DeGolia, S. G., Dunai, M., Tate, D. L., & Strong, C. M. (1998). Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states. JOURNAL OF CLINICAL PSYCHIATRY, 59(2), 83-85.

Psychosensory symptoms in bipolar disorder
Ali, S. O., Denicoff, K. D., Ketter, T. A., SmithJackson, E. E., & Post, R. M. (1997). Psychosensory symptoms in bipolar disorder. NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 10(4), 223-231.

Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients
Marangell, L. B., George, M. S., Callahan, A. M., Ketter, T. A., Pazzaglia, P. J., & Post, R. M. (1997). Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. ARCHIVES OF GENERAL PSYCHIATRY, 54(3), 214-222.

Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders
Marangell, L. B., Ketter, T. A., George, M. S., Pazzaglia, P. J., Callahan, A. M., & Post, R. M. (1997). Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. AMERICAN JOURNAL OF PSYCHIATRY, 154(2), 224-230.

Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: Confounding effects of tolerance and implications for therapeutics
Callahan, A. M., Frye, M. A., Marangell, L. B., George, M. S., Ketter, T. A., & Post, R. M. (1997). Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: Confounding effects of tolerance and implications for therapeutics. BIOLOGICAL PSYCHIATRY, 41(3), 264-272.

Blunted left cingulate activation in mood disorder subjects during a response interference task (the stroop)
George, M. S., Ketter, T. A., Parekh, P. I., ROSINSKY, N., Ring, H. A., & Post, R. M. (1997). Blunted left cingulate activation in mood disorder subjects during a response interference task (the stroop). JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 9(1), 55-63.

Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness
George, M. S., Ketter, T. A., Parekh, P. I., Herscovitch, P., & Post, R. M. (1996). Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. BIOLOGICAL PSYCHIATRY, 40(9), 859-871.

The place of anticonvulsant therapy in bipolar illness
Post, R. M., Ketter, T. A., Denicoff, K., Pazzaglia, P. J., Leverich, G. S., & Frye, M. A. (1996). The place of anticonvulsant therapy in bipolar illness. PSYCHOPHARMACOLOGY, 128(2), 115-129.

Evaluating the clinical significance of drug interactions: A systematic approach
Callahan, A. M., Marangell, L. B., & Ketter, T. A. (1996). Evaluating the clinical significance of drug interactions: A systematic approach. HARVARD REVIEW OF PSYCHIATRY, 4(3), 153-158.

Understanding emotional prosody activates right hemisphere regions
George, M. S., Parekh, P. I., ROSINSKY, N., Ketter, T. A., Kimbrell, T. A., & Post, R. M. (1996). Understanding emotional prosody activates right hemisphere regions. ARCHIVES OF NEUROLOGY, 53(7), 665-670.

Felbamate monotherapy has stimulant-like effects in patients with epilepsy
Ketter, T. A., Malow, B. A., Flamini, R., Ko, D., White, S. R., & Theodore, W. H. (1996). Felbamate monotherapy has stimulant-like effects in patients with epilepsy. EPILEPSY RESEARCH, 23(2), 129-137.

Reply to letter from Swartz on "Mania and lower serum cholesterol levels.
Callahan, A. M., Ketter, T. A., CRUMLISH, J., Parekh, P., Brown, D. W., & Post, R. M. (1996). Reply to letter from Swartz on "Mania and lower serum cholesterol levels. Journal of clinical psychopharmacology, 16(1), 95-97.

Functional brain imaging, limbic function, and affective disorders
Ketter, T. A., George, M. S., Kimbrell, T. A., Benson, B. E., & Post, R. M. (1996). Functional brain imaging, limbic function, and affective disorders. NEUROSCIENTIST, 2(1), 55-65.

Functional brain imaging, limbic function, and affective disorders.
Ketter TA, George MS, Kimbrell TA, Benson BE, & Post RM. (1996). Functional brain imaging, limbic function, and affective disorders. The Neuroscientist, 1(2).

Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences
Ketter, T. A., Andreason, P. J., George, M. S., Lee, C., Gill, D. S., & Post, R. M. (1996). Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. ARCHIVES OF GENERAL PSYCHIATRY, 53(1), 59-69.

Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls
Little, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., & Post, R. M. (1996). Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. PSYCHOPHARMACOLOGY BULLETIN, 32(4), 629-635.

Rational polypharmacy in the bipolar affective disorders.
Post, R. M., Ketter, T. A., Pazzaglia, P. J., Denicoff, K., George, M. S., & Frye, M. (1996). Rational polypharmacy in the bipolar affective disorders. Epilepsy research. Supplement, 11, 153-180.

Developmental psychobiology of cyclic affective illness: Implications for early therapeutic intervention
Post, R. M., Weiss, S. Rb., Leverich, G. S., George, M. S., Frye, M., & Ketter, T. A. (1996). Developmental psychobiology of cyclic affective illness: Implications for early therapeutic intervention. DEVELOPMENT AND PSYCHOPATHOLOGY, 8(1), 273-305.

THE EMERGING ROLE OF CYTOCHROME-P450 3A IN PSYCHOPHARMACOLOGY
Ketter, T. A., Flockhart, D. A., Post, R. M., Denicoff, K., Pazzaglia, P. J., & Callahan, A. M. (1995). THE EMERGING ROLE OF CYTOCHROME-P450 3A IN PSYCHOPHARMACOLOGY. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 15(6), 387-398.

FELBAMATE MONOTHERAPY - IMPLICATIONS FOR ANTIEPILEPTIC DRUG DEVELOPMENT
Theodore, W. H., Albert, P., Stertz, B., Malow, B., Ko, D., & Ketter, T. (1995). FELBAMATE MONOTHERAPY - IMPLICATIONS FOR ANTIEPILEPTIC DRUG DEVELOPMENT. EPILEPSIA, 36(11), 1105-1110.

DAILY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) IMPROVES MOOD IN DEPRESSION
George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., & Post, R. M. (1995). DAILY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) IMPROVES MOOD IN DEPRESSION. NEUROREPORT, 6(14), 1853-1856.

CARBAMAZEPINE BUT NOT VALPROATE INDUCES BUPROPION METABOLISM
Ketter, T. A., Jenkins, J. B., SCHROEDER, D. H., Pazzaglia, P. J., Marangell, L. B., & Post, R. M. (1995). CARBAMAZEPINE BUT NOT VALPROATE INDUCES BUPROPION METABOLISM. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 15(5), 327-333.

ADDITION OF MONOAMINE-OXIDASE INHIBITORS TO CARBAMAZEPINE - PRELIMINARY EVIDENCE OF SAFETY AND ANTIDEPRESSANT EFFICACY IN TREATMENT-RESISTANT DEPRESSION
Ketter, T. A., Post, R. M., Parekh, P. I., & Worthington, K. (1995). ADDITION OF MONOAMINE-OXIDASE INHIBITORS TO CARBAMAZEPINE - PRELIMINARY EVIDENCE OF SAFETY AND ANTIDEPRESSANT EFFICACY IN TREATMENT-RESISTANT DEPRESSION. JOURNAL OF CLINICAL PSYCHIATRY, 56(10), 471-475.

Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity.
Parekh, P. I., Spencer, J. W., George, M. S., Gill, D. S., Ketter, T. A., & Post, R. M. (1995). Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity. Brain topography, 7(3), 209-216.

BRAIN ACTIVITY DURING TRANSIENT SADNESS AND HAPPINESS IN HEALTHY WOMEN
George, M. S., Ketter, T. A., Parekh, P. I., Horwitz, B., Herscovitch, P., & Post, R. M. (1995). BRAIN ACTIVITY DURING TRANSIENT SADNESS AND HAPPINESS IN HEALTHY WOMEN. AMERICAN JOURNAL OF PSYCHIATRY, 152(3), 341-351.

ACTIVATION STUDIES IN MOOD DISORDERS
George, M. S., Ketter, T. A., & Post, R. M. (1994). ACTIVATION STUDIES IN MOOD DISORDERS. PSYCHIATRIC ANNALS, 24(12), 648-652.

PRIMARY MOOD DISORDERS - STRUCTURAL AND RESTING FUNCTIONAL-STUDIES
Ketter, T. A., George, M. S., Ring, H. A., Pazzaglia, P., Marangell, L., & Post, R. M. (1994). PRIMARY MOOD DISORDERS - STRUCTURAL AND RESTING FUNCTIONAL-STUDIES. PSYCHIATRIC ANNALS, 24(12), 637-642.

SPATIAL ABILITY IN AFFECTIVE-ILLNESS - DIFFERENCES IN REGIONAL BRAIN ACTIVATION DURING A SPATIAL MATCHING TASK (H2O)-O-15 PET)
George, M. S., Ketter, T. A., Parekh, P., Gill, D. S., Huggins, T., & Post, R. M. (1994). SPATIAL ABILITY IN AFFECTIVE-ILLNESS - DIFFERENCES IN REGIONAL BRAIN ACTIVATION DURING A SPATIAL MATCHING TASK (H2O)-O-15 PET). NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 7(3), 143-153.

ANTICONVULSANT WITHDRAWAL-EMERGENT PSYCHOPATHOLOGY
Ketter, T. A., Malow, B. A., Flamini, R., White, S. R., Post, R. M., & Theodore, W. H. (1994). ANTICONVULSANT WITHDRAWAL-EMERGENT PSYCHOPATHOLOGY. NEUROLOGY, 44(1), 55-61.

Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop.
George, M. S., Ketter, T. A., Parekh, P. I., ROSINSKY, N., Ring, H., & Post, R. M. (1994). Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Human brain mapping, 1(3), 194-209.

PRELIMINARY CONTROLLED TRIAL OF NIMODIPINE IN ULTRA-RAPID CYCLING AFFECTIVE DYSREGULATION
Pazzaglia, P. J., Post, R. M., Ketter, T. A., George, M. S., & Marangell, L. B. (1993). PRELIMINARY CONTROLLED TRIAL OF NIMODIPINE IN ULTRA-RAPID CYCLING AFFECTIVE DYSREGULATION. PSYCHIATRY RESEARCH, 49(3), 257-272.

SPECT AND PET IMAGING IN MOOD DISORDERS
George, M. S., Ketter, T. A., & Post, R. M. (1993). SPECT AND PET IMAGING IN MOOD DISORDERS. JOURNAL OF CLINICAL PSYCHIATRY, 54, 6-13.

BRAIN-REGIONS INVOLVED IN RECOGNIZING FACIAL EMOTION OR IDENTITY - AN O-15 PET STUDY
George, M. S., Ketter, T. A., Gill, D. S., Haxby, J. V., Ungerleider, L. G., & Post, R. M. (1993). BRAIN-REGIONS INVOLVED IN RECOGNIZING FACIAL EMOTION OR IDENTITY - AN O-15 PET STUDY. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 5(4), 384-394.

ANTIDEPRESSANT RESPONSE TO SLEEP-DEPRIVATION AS A FUNCTION OF TIME INTO DEPRESSIVE EPISODE IN RAPIDLY CYCLING BIPOLAR PATIENTS
Gill, D. S., Ketter, T. A., & Post, R. M. (1993). ANTIDEPRESSANT RESPONSE TO SLEEP-DEPRIVATION AS A FUNCTION OF TIME INTO DEPRESSIVE EPISODE IN RAPIDLY CYCLING BIPOLAR PATIENTS. ACTA PSYCHIATRICA SCANDINAVICA, 87(2), 102-109.

NEW DEVELOPMENTS IN THE USE OF ANTICONVULSANTS AS MOOD STABILIZERS
Post, R. M., Ketter, T. A., Pazzaglia, P. J., George, M. S., Marangell, L., & Denicoff, K. (1993). NEW DEVELOPMENTS IN THE USE OF ANTICONVULSANTS AS MOOD STABILIZERS. NEUROPSYCHOBIOLOGY, 27(3), 132-137.

CARBAMAZEPINE-INDUCED INCREASES IN TOTAL SERUM-CHOLESTEROL - CLINICAL AND THEORETICAL IMPLICATIONS
Brown, D. W., Ketter, T. A., CRUMLISH, J., & Post, R. M. (1992). CARBAMAZEPINE-INDUCED INCREASES IN TOTAL SERUM-CHOLESTEROL - CLINICAL AND THEORETICAL IMPLICATIONS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 12(6), 431-437.

CEREBRAL METABOLISM AND DEPRESSION IN PATIENTS WITH COMPLEX PARTIAL SEIZURES
Bromfield, E. B., Altshuler, L., Leiderman, D. B., Balish, M., Ketter, T. A., & Theodore, W. H. (1992). CEREBRAL METABOLISM AND DEPRESSION IN PATIENTS WITH COMPLEX PARTIAL SEIZURES. ARCHIVES OF NEUROLOGY, 49(6), 617-623.

PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .2.
Ketter, T. A., Post, R. M., & Worthington, K. (1991). PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .2. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 11(5), 306-312.

PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .1.
Ketter, T. A., Post, R. M., & Worthington, K. (1991). PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .1. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 11(3), 198-203.

LACK OF BENEFICIAL-EFFECTS OF L-BACLOFEN IN AFFECTIVE-DISORDER
Post, R. M., Ketter, T. A., Joffe, R. T., & KRAMLINGER, K. L. (1991). LACK OF BENEFICIAL-EFFECTS OF L-BACLOFEN IN AFFECTIVE-DISORDER. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 6(4), 197-207.

Antiepileptic drugs in affective illness. Clinical and theoretical implications.
Post, R. M., Altshuler, L. L., Ketter, T. A., Denicoff, K., & Weiss, S. R. (1991). Antiepileptic drugs in affective illness. Clinical and theoretical implications. Advances in neurology, 55, 239-277.

TREATMENT OF RAPID CYCLING BIPOLAR ILLNESS
Post, R. M., Kramlinger, K. G., Altshuler, L. L., Ketter, T., & Denicoff, K. (1990). TREATMENT OF RAPID CYCLING BIPOLAR ILLNESS. PSYCHOPHARMACOLOGY BULLETIN, 26(1), 37-47.

PERSPECTIVES ON THE MECHANISM OF ACTION OF ELECTROCONVULSIVE-THERAPY - ANTICONVULSANT, PEPTIDERGIC, AND C-FOS PROTO-ONCOGENE EFFECTS
Nakajima, T., Post, R. M., Pert, A., Ketter, T. A., & Weiss, S. Rb. (1989). PERSPECTIVES ON THE MECHANISM OF ACTION OF ELECTROCONVULSIVE-THERAPY - ANTICONVULSANT, PEPTIDERGIC, AND C-FOS PROTO-ONCOGENE EFFECTS. CONVULSIVE THERAPY, 5(3), 274-295.